Abstract
Background
Our case explored the spectrum of autoimmune and infectious neurological complications of Coronavirus Disease 2019. In addition, we also reviewed and discussed clinical features, neuroimaging, CSF findings, and outcomes in patients with COVID-19-associated Myelin Oligodendrocyte Glycoprotein Antibody Disorder (MOGAD) CNS inflammatory disorder.
Case presentation
Here we presented a case of post-Coronavirus Disease 2019 infection Myelin Oligodendrocyte Glycoprotein Antibody Disorder in a 41-year-old male who presented with gait instability, urinary retention, and confusion. Workup done in hospital showed transverse myelitis in cervical spine region and left optic neuritis. Laboratory findings showed Myelin Oligodendrocyte Glycoprotein-IgG antibodies were positive in serum (1:100), suggestive of post-COVID Myelin Oligodendrocyte Glycoprotein Antibody Disorder.
Conclusion
To our knowledge, this is the first comprehensive case report and the literature review that includes the clinical features, neuroimaging, CSF findings, and outcomes in COVID-19-associated Myelin Oligodendrocyte Glycoprotein Antibody Disorder.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 West Virginia University, School of Medicine, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
2 West Virginia Clinical and Translational Science Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
3 Kathmandu Medical College Teaching Hospital, Kathmandu, Nepal (GRID:grid.415089.1) (ISNI:0000 0004 0442 6252)
4 Minia University, Department of Neuropsychiatry, Minia, Egypt (GRID:grid.411806.a) (ISNI:0000 0000 8999 4945)
5 West Virginia University, Department of Biostatistics, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
6 West Virginia University, School of Medicine, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia Clinical and Translational Science Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Neurology, Rockefeller Neuroscience Institute, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)